US Edition
Published • loading... • Updated
Researcher Awarded $2.75M NIH Grant to Develop Next-Gen Cancer Treatments
Summary by Newswise
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Researcher Awarded $2.75M NIH Grant to Develop Next-Gen Cancer Treatments
A leading expert in antibody-drug-conjugate (ADC) technology, Binghamton University , State University of New York Professor of Pharmaceutical Sciences L. Nathan Tumey has worked for nearly two decades developing new approaches for the treatment of cancer. Now, thanks to a substantial $2.75M grant from the National Institutes of Health, Tumey is taking an exciting step forward in his research -- leading the charge to transition this exciting tec…
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
